top of page

9/6 - 9/13 North America Healthcare Market Weekly Report

<Weekly Report>


[1] Covax Cuts Its 2021 Forecast for Available Doses by Quarter - The New York Times (

[2]Biden’s New Vaccine Requirements Draw Praise, Condemnation and Caution - The New York Times (



[5] CMS to require staff at hospitals and other facilities to get COVID-19 vaccine or risk funding loss | FierceHealthcare

[6] Pandemic relief funds were unevenly distributed, didn't account for community burden: Health Affairs | Healthcare Dive

[7]Moderna expands mRNA vaccine supply in deal with new biotech producer | Healthcare Dive

[8] HHS releases $25.5B in COVID-19 relief funding targeted at smaller providers | FierceHealthcare

[9]More Asia-Pacific countries warily ease their tough anti-Covid rules. - The New York Times (

[10] The C.D.C. reports that unvaccinated Americans are 11 times more likely to die if infected: The week in Covid news. - The New York Times (

[11] Roche bets big on off-the-shelf cancer cell therapy with Adaptimmune deal | BioPharma Dive

[12]Sanofi to buy Kadmon for $1.9B, extending deal streak | BioPharma Dive

[13] Lilly joins RNA editing race with ProQR deal | BioPharma Dive

[14] Biogen offered a window into what's holding up Aduhelm. Investors didn't like what they saw. | Healthcare Dive

[15]Biden admin shells out $452M to boost state reinsurance programs | Healthcare Dive

[16] Industry pushes for more time before surprise billing ban enforced | Healthcare Dive

[17]Disparities in opioid overdose deaths continue to worsen for Black people, study suggests | National Institutes of Health (NIH)

[18] Biden pushes forward on Medicare price negotiation | BioPharma Dive


[20]Biden-Harris Administration Invests $20 Million in American Rescue Plan Funding to Improve Access to Affordable and Comprehensive Health Insurance |

1 view0 comments
bottom of page